SCHEMBL25867963

SCHEMBL25867963

O=c1[nH]c(=O)c2ccc3c4ccccc4[nH]c4ccc1c2c43

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.57
ALDH1A1 P00352 4/20 0.57
KDM4E B2RXH2 4/20 0.57
GPR3 P46089 2/20 0.57
HSD17B10 Q99714 2/20 0.57
LMNA P02545 2/20 0.57
MEN1 O00255 1/20 0.57
TNKS O95271 1/20 0.57
CYP1A2 P05177 1/20 0.57
BLM P54132 1/20 0.57
PMP22 Q01453 1/20 0.57
KMT2A Q03164 1/20 0.57
PARP15 Q460N3 1/20 0.57
TNKS2 Q9H2K2 1/20 0.57
GABRP O00591 1/20 0.55
GABRD O14764 1/20 0.55
GABRA1 P14867 1/20 0.55
GABRB1 P18505 1/20 0.55
GABRG2 P18507 1/20 0.55
GABRB3 P28472 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25836500 0.85 PARP1 (0.57) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL23132411 0.85 PARP1 (0.57) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL25836125 0.85 GABRP (0.65) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL25836123 0.85 AHR (0.56) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL25835163 0.84 GABRP (0.64) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL25836015 0.84 PARP1 (0.51) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL13792143 0.84 ALDH1A1 (0.59) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL23132415 0.83 PARP1 (0.64) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL17471015 0.82 F2 (0.53) PARP1ALDH1A1KDM4EGPR3HSD17B10
SCHEMBL20226386 0.82 GABRP (0.64) PARP1ALDH1A1KDM4EGPR3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235217-A1 LUMINESCENT COMPOUND, METHOD FOR PRODUCING LUMINESCENT COMPOUND, LUMINESCENT COMPOSITION, LUMINESCENT THIN FILM AND LUMINESCENT PARTICLES Konica Minolta, Inc. (JP) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235217-A1 LUMINESCENT COMPOUND, METHOD FOR PRODUCING LUMINESCENT COMPOUND, LUMINESCENT COMPOSITION, LUMINESCENT THIN FILM AND LUMINESCENT PARTICLES SCLY, SOD1, GPX1 PARP1 1996/4885ALDH1A1 835/4885KDM4E 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.